Antibacterial and antibiofilm effects of sodium hypochlorite against Staphylococcus aureus isolates derived from patients with atopic dermatitis

British Journal of Dermatology

Volumn 177, Issue 2, 2017, Pages 513-521

  Eriksson, S ^a,b   van der Plas, M J A ^b   Morgelin M ^b   Sonesson, A ^a,b  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRIN; HYPOCHLORITE SODIUM; ANTIINFECTIVE AGENT; DISINFECTANT AGENT;

ANTIBACTERIAL ACTIVITY; ARTICLE; ATOPIC DERMATITIS; BACTERIUM ISOLATE; BIOFILM; CONFOCAL LASER SCANNING MICROSCOPY; CONTROLLED STUDY; DIFFUSION; DRUG EFFECT; GROWTH INHIBITION; HUMAN; HUMAN TISSUE; NONHUMAN; PRIORITY JOURNAL; PUNCH BIOPSY; SCANNING ELECTRON MICROSCOPY; SKIN BIOPSY; SKIN SURFACE; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; BATH; COMPLICATION; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; PHYSIOLOGY; SKIN; STAPHYLOCOCCAL SKIN INFECTION;

ANTI-BACTERIAL AGENTS; BATHS; BIOFILMS; DERMATITIS, ATOPIC; DISINFECTANTS; HUMANS; MICROBIAL SENSITIVITY TESTS; SKIN; SODIUM HYPOCHLORITE; STAPHYLOCOCCAL SKIN INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 85021698949     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.15410     Document Type: Article

References (25)

1. Weidinger S, Novak N. Atopic dermatitis. Lancet 2016; 387:1109–22.
2. Biedermann T. Dissecting the role of infections in atopic dermatitis. Acta Derm Venereol 2006; 86:99–109.
3. Allen HB, Vaze ND, Choi C et al. The presence and impact of biofilm-producing staphylococci in atopic dermatitis. JAMA Dermatol 2014; 150:260–5.
4. Otto M. Staphylococcal infections: mechanisms of biofilm maturation and detachment as critical determinants of pathogenicity. Annu Rev Med 2013; 64:175–88.
5. Vlassova N, Han A, Zenilman JM et al. New horizons for cutaneous microbiology: the role of biofilms in dermatological disease. Br J Dermatol 2011; 165:751–9.
6. Wilkins M, Hall-Stoodley L, Allan RN et al. New approaches to the treatment of biofilm-related infections. J Infect 2014; 69 (Suppl. 1):S47–52.
7. Batoni G, Maisetta G, Esin S. Antimicrobial peptides and their interaction with biofilms of medically relevant bacteria. Biochim Biophys Acta 2016; 1858:1044–60.
8. Clausen ML, Slotved HC, Krogfelt KA et al. In vivo expression of antimicrobial peptides in atopic dermatitis. Exp Dermatol 2016; 25:3–9.
9. Bath-Hextall FJ, Birnie AJ, Ravenscroft JC et al. Interventions to reduce Staphylococcus aureus in the management of atopic eczema: an updated Cochrane review. Br J Dermatol 2010; 163:12–26.
10. Wong SM, Ng TG, Baba R. Efficacy and safety of sodium hypochlorite (bleach) baths in patients with moderate to severe atopic dermatitis in Malaysia. J Dermatol 2013; 40:874–80.
11. Barnes TM, Greive KA. Use of bleach baths for the treatment of infected atopic eczema. Australas J Dermatol 2013; 54:251–8.
12. Ryan C, Shaw RE, Cockerell CJ et al. Novel sodium hypochlorite cleanser shows clinical response and excellent acceptability in the treatment of atopic dermatitis. Pediatr Dermatol 2013; 30:308–15.
13. Sonesson A, Kasetty G, Olin AI et al. Thymic stromal lymphopoietin exerts antimicrobial activities. Exp Dermatol 2011; 20:1004–10.
14. Hell E, Giske CG, Nelson A et al. Human cathelicidin peptide LL37 inhibits both attachment capability and biofilm formation of Staphylococcus epidermidis. Lett Appl Microbiol 2010; 50:211–5.
15. Ceri H, Olson ME, Stremick C et al. The Calgary Biofilm Device: new technology for rapid determination of antibiotic susceptibilities of bacterial biofilms. J Clin Microbiol 1999; 37:1771–6.
16. Jinnestal CL, Belfrage E, Back O et al. Skin barrier impairment correlates with cutaneous Staphylococcus aureus colonization and sensitization to skin-associated microbial antigens in adult patients with atopic dermatitis. Int J Dermatol 2014; 53:27–33.
17. Tote K, Horemans T, Vanden Berghe D et al. Inhibitory effect of biocides on the viable masses and matrices of Staphylococcus aureus and Pseudomonas aeruginosa biofilms. Appl Environ Microbiol 2010; 76:3135–42.
18. Huang JT, Abrams M, Tlougan B et al. Treatment of Staphylococcus aureus colonization in atopic dermatitis decreases disease severity. Pediatrics 2009; 123:e808–14.
19. Morrissey I, Oggioni MR, Knight D et al. Evaluation of epidemiological cut-off values indicates that biocide resistant subpopulations are uncommon in natural isolates of clinically-relevant microorganisms. PLoS One 2014; 9:e86669.
20. Archer NK, Mazaitis MJ, Costerton JW et al. Staphylococcus aureus biofilms: properties, regulation, and roles in human disease. Virulence 2011; 2:445–59.
21. Kong HH, Oh J, Deming C et al. Temporal shifts in the skin microbiome associated with disease flares and treatment in children with atopic dermatitis. Genome Res 2012; 22:850–9.
22. Gonzalez ME, Schaffer JV, Orlow SJ et al. Cutaneous microbiome effects of fluticasone propionate cream and adjunctive bleach baths in childhood atopic dermatitis. J Am Acad Dermatol 2016; 75:481–93.
23. Hon KL, Tsang YC, Lee VW et al. Efficacy of sodium hypochlorite (bleach) baths to reduce Staphylococcus aureus colonization in childhood onset moderate-to-severe eczema: a randomized, placebo-controlled cross-over trial. J Dermatolog Treat 2016; 27:156–62.
24. Nakatsuji T, Chen TH, Two AM et al. Staphylococcus aureus exploits epidermal barrier defects in atopic dermatitis to trigger cytokine expression. J Invest Dermatol 2016; 136:2192–200.
25. Shi VY, Foolad N, Ornelas JN et al. Comparing the effect of bleach and water baths on skin barrier function in atopic dermatitis: a split-body randomized controlled trial. Br J Dermatol 2016; 175:212–4.